|
Stock Profiler.US: Stocks on the Radar: GGLB, FMNJ, PASO, APPY
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:08072008
New York, NY - Green Globe International, Inc. (OTCBB: GGLB); Franklin
Mining, Inc. (PINKSHEETS: FMNJ) (FRANKFURT: FMJ); Patient Access
Solutions Inc. (OTCBB: PASO); AspenBio Pharma, Inc. (NASDAQ: APPY)
Stock Profiler.US, LLC welcomes Investors and Companies alike to join
us in our pursuit of excellence. Companies who want to broadcast their
message are encouraged to contact us at www.stockprofiler.us. Sign up
for our Free Newsletter at www.stockprofiler.us.
-------------------------------------------
Green Globe International, Inc. (OTCBB: GGLB) closed at $0.0032 Monday,
trading 65,541,655 shares.
Company News- July 7, 2008: Green Globe International, Inc. Announces
Initial Agreement With PA Consulting Group for Collaboration on
Sustainability Projects
Green Globe International, Inc. (OTCBB: GGLB), which owns the Green
Globe brand, the premier international green brand focused on
sustainability and carbon neutrality programs, announced yesterday that
it has entered into an initial agreement in the form of a Memorandum of
Understanding with PA Consulting Group, a leading global management
consultancy company. Green Globe International and PA Consulting Group
plan to cooperate in several specified areas related to the delivery of
sustainability programs under the Green Globe banner.
Under terms of the MOU, the areas of collaboration between PA
Consulting Group and Green Globe International, Inc., include, but are
not limited to: 1) identify potential tourism destinations (e.g.,
countries, territories, municipalities, and resort areas) for Green
Globe International programs; 2) secure the support and participation
of key stakeholders in the destination; 3) design and develop a
destination-specific Sustainability and Carbon Neutrality Plan; 4) work
with Green Globe International to secure funds to finance the
implementation of the Sustainability and Carbon Neutrality Plan; 5)
manage the implementation of the Sustainability and Carbon Neutrality
Plan; 6) monitor and report progress toward key sustainability and
carbon generation indicators for Energy consumption; Waste production;
Water usage; Chemical usage; Community Engagement, and local economic
benefit; 6) certify that communities and businesses are compliant with
the Green Globe Benchmarking and Certification Programs available; and
7) provide an annual review to confirm compliance with Benchmarking
Standards which qualify for Certification.
After meetings with Caribbean tourism organizations and officials,
Green Globe International recently announced plans to deliver
sustainability and carbon neutrality solutions for the region. Green
Globe International will further seek to expand these programs to
countries and destinations worldwide.
Steven R. Peacock, chief executive officer and managing director of
Green Globe International, Inc., commented, "We are extremely pleased
to have established a relationship with PA Consulting Group and believe
that they will be a tremendous partner for Green Globe and will assist
greatly in the implementation of our sustainability programs.
"The support of PA Consulting Group is expected to contribute
significantly to the success of the Green Globe program, particularly
as we seek to expand the awareness of our Sustainability and Carbon
Neutrality Plans for destinations and countries that are concerned with
the quality of their environment. As this agreement details, we also
anticipate that PA will play an integral role in the implementation of
Green Globe programs to the participating destinations and countries."
According to Bill Meade, Partner with PA Consulting Group, "Green Globe
has provided a roadmap for governments, companies, and communities
interested in applying environmental and social sustainability programs
to the tourism sector."
PA has helped over 50 hotels, resorts and tourism attractions become
Green Globe benchmarked and certified, and three tourism destinations
become Green Globe benchmarked. PA was instrumental in introducing
Green Globe to Caribbean and Middle East tourism markets, including
helping the first four hotels in the world, all from Jamaica, become
Green Globe certified.
"We are excited about the inclusion of carbon neutrality to the Green
Globe program as the global tourism industry, host country governments,
and private businesses are seeking to reduce their 'carbon footprint'
and participate in international carbon trading and financing schemes,"
Mr. Meade added.
The World Travel and Tourism Council (WTTC) established Green Globe in
1992 as a response to the United Nations Rio de Janeiro Earth Summit,
where 182 Heads of State endorsed the Agenda 21 principles of
Sustainable Development. Green Globe is the only international
sustainability program based on Agenda 21 principles.
Green Globe International (www.greenglobeint.com) encourages all
shareholders and others interested in following the progress of the
company to subscribe to receive email alerts whenever new information
is made public. To subscribe, please visit
http://www.greenglobeint.com/stayconnected/email/.
About PA Consulting Group
PA Consulting Group is an independent, employee-owned, global firm of
3,000 talented individuals, operating from offices across the world, in
Europe, North America, Latin America, Asia, and Oceania. PA has won
numerous awards for delivering complex and highly innovative
assignments, run one of the most successful venture programmes in the
consulting industry, technology development capability that few firms
can match, deep expertise across key industries and government, and a
unique breadth of skills from strategy to IT to HR to applied
technology. PA has earned a worldwide reputation for transforming the
performance of organizations.
About Green Globe International, Inc.
Green Globe International, Inc. is the majority owner of Green Globe,
Ltd., a British company that owns the Green Globe brand, the premier
international brand for sustainable travel, tourism and related green
businesses. Green Globe's worldwide network extends across 30
countries. For information on Green Globe's benchmarking and
certification please visit
http://www.ec3global.com/products-programs/green-globe/Default.aspx.
For more information on Green Globe International, please visit
www.greenglobeint.com.
-------------------------------------------
Franklin Mining, Inc. (PINKSHEETS: FMNJ) (FRANKFURT: FMJ) closed at
$0.0019 Monday, trading 73,997,378 shares.
Company News- July 8, 2008: Franklin Expands US Energy Subsidiary and
Establishes Franklin Mining Colombia LTDA
Franklin Mining, Inc. (PINKSHEETS: FMNJ) (FRANKFURT: FMJ) Chairman and
President, William A. Petty, announced earlier today that ongoing
negotiations for US energy projects have resulted in a significant
change in previously announced plans for the company's US energy
division. Franklin Mining, Inc. has retained full ownership of the
recently formed subsidiary, Franklin Oil & Gas, Inc., and is prepared
to begin work in west Texas.
Mr. Petty also announced that incorporation documents have been
prepared for formation of Franklin Mining Colombia LTDA and all
requested information has been submitted to ECOPETROL (Colombia's
national oil company) to register future crude oil sales.
About Franklin Mining, Inc
Franklin Mining, Inc. has mining and energy interests in the United
States and Bolivia as well as energy interests in Argentina. Franklin
Mining, Bolivia is a wholly owned subsidiary. Franklin Mining, Inc.
holds 51% ownership in both Franklin Oil & Gas, Bolivia S.A. and
Franklin Oil & Gas, Argentina S.A. Additional information is available
at www.FranklinMining.com.
-------------------------------------------
Patient Access Solutions Inc. (OTCBB: PASO) closed at $0.97 Monday,
trading 497,400 shares.
Company News- July 8, 2008: Patient Access Solutions Inc. Corporate
Update
Earlier today the following was announced:
Bruce Weitzberg, President and CEO of Patient Access Solutions Inc.
(OTCBB: PASO), a leading provider of healthcare/financial processing
solutions for the healthcare, homecare and dental industries , would
like to present its shareholders with a Corporate update.
Sales for the six month period ending April 30, 2008 compared to the
same period last year (2007) increased by 80%.
PAS has hired of a new VP of Sales with over 18 years of technology
industry experience
In early June 2008, PAS completed the second layer of integration
between digital paper technology and the PAS web portal -- thereby,
allowing full, seamless, eligibility and benefit verification
transactions, from paper/pen through the PAS network to over 750
insurance companies and plans.
In May 2008, PAS completed their new updated interactive claims
analyzer web portal. This new portal allows healthcare providers to
monitor claims status from submission to payment, all from their
desktop computer. Additionally PAS has instituted ERA (Electronic
Remittance Advice) which allows healthcare providers to receive
payments from insurance companies via electronic wire in lieu of paper
checks.
We recently started 3 different pilot programs with 3 major Home
Healthcare Agencies located in North America, with over 35,000 nurses
combined, and so far the feedback has been extremely positive. We are
currently beginning contract discussions with one of the major Home
Healthcare Agencies.
Bruce Weitzberg stated, "We will continue to keep you updated as our
business progresses. As always, we appreciate your ongoing support and
look forward to a very successful 2008!"
About Patient Access Solutions Inc. (www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions
company which has created a formidable array of technology, resources
and allies to enable it to become an agent of radical change in what
has traditionally been a slowly evolving healthcare environment.
The PASHealth Web Portal System and terminal-based solutions offer
electronic medical eligibility, electronic referrals and service
authorizations, electronic claims processing, drug formularies,
electronic prescriptions, electronic medical records and patient data,
automating the labor-intensive and expensive manual process currently
used by many facilities and healthcare providers. Our D-PAS product
utilizes digital pen & paper technology, to capture handwritten
information from the doctor or office personnel, transfer it into a
digital form into the PAS web portal and utilize the data to initiate
workflows in a secure environment. A patient's medical history and
patient records are used to initiate necessary workflows within the web
portal, securely and much more efficiently, empowering the healthcare
business process. In addition, the Web Portal System offers a complete
suite of self pay receivable management solutions for the healthcare
facilities.
-------------------------------------------
AspenBio Pharma, Inc. (NASDAQ: APPY) closed at $5.86 Monday, trading
51,800 shares.
Company News- July 8, 2008: Michael R. Merson Joins AspenBio Pharma's
Board of Directors
Earlier today the following was announced:
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical
company dedicated to the development of novel drugs and diagnostics for
humans and animals, has appointed Michael R. Merson as a new
independent member of its board of directors. This appointment brings
the total number of company directors to seven, with five serving
independently.
Merson is a highly seasoned health care executive, having founded and
managed several healthcare organizations, from hospitals to health
insurers. Since 2004, he has served as chairman of CareFirst Blue
Cross/Blue Shield, the 16th largest health insurer in the United
States, with annual revenues of approximately $7.0 billion and more
than 3.2 million insured individuals. CareFirst is part of the
BlueCross/Blue Shield group of insurance providers which collectively
covers more than 100 million people in the United States.
Merson has a 30-year record of growth and development in the health
care industry, including as president and CEO of Franklin Square
Hospital (1982-1987), various positions including president and CEO of
Helix Health, Inc. (1987-1998), and president of MedStar Health
(1998-1999). Through Michael R. Merson, LLC and Yaffe & Company, he
currently provides consulting services to primarily healthcare related
enterprises, focusing on mergers and acquisitions, goal setting,
business and governance issues, and executive compensation and
benefits.
Merson has been active with the Maryland Hospital Association,
including participating on its executive council and receiving its
Distinguished Service Award. He also served as its chair of the
professional practices committee and the rate regulation council.
Merson has served on the boards of the Maryland Hospital Education
Institute and the National Blood Association, in addition to serving on
the board and executive committee of AmHS/Premier, Inc. Merson received
his MBA in Health Care Administration from The George Washington
University.
"We are pleased to have someone with Michael's knowledge, wisdom and
experience, join our board of directors," said Greg Pusey, AspenBio
Pharma's chairman. "His healthcare expertise from a hospital and
insurance perspective, combined with hands-on experience in founding
and growing successful organizations, greatly benefits our board at
this important stage in our development and as we pursue many exciting
opportunities."
About AspenBio Pharma
AspenBio Pharma is an emerging bio-pharmaceutical company dedicated to
the discovery; development, manufacture, and marketing of novel
proprietary products, including those that enhance the reproductive
efficiency of animals and that have large worldwide market potential.
The company was originally formed to produce purified proteins for
diagnostic applications and has become a leading supplier of human
hormones to many of the nation's largest medical diagnostic companies
and research institutions. The company has successfully leveraged this
foundational science and technology expertise to rapidly develop an
enviable late-stage pipeline of several novel reproduction hormone
analogs for wide-ranging therapeutic use initially in bovine and equine
species. AspenBio Pharma continues to advance the development and
testing of its two first-generation blood-based human diagnostic tests
designed to rapidly help diagnose or rule out appendicitis in patients
complaining of abdominal pain. For more information, go to
www.aspenbiopharma.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the
statements made in this opinion. This opinion contains forward-looking
statements that involve risks and uncertainties. This material is for
informational purposes only and should not be construed as an offer or
solicitation of an offer to buy or sell securities. Stockprofiler.US
affiliates has not been compensated for services rendered;
Stockprofiler.US affiliates is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter.
Please consult a broker before purchasing or selling any securities
mentioned herein. To view full disclaimers, go to www.stockprofiler.us)
(disclaimers).
CONTACT: StockProfiler.US
e-mail: info@stockprofiler.us
WWW: http://www.stockprofiler.us
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 16-18, 2008. Los Angeles, California.
